Both in Medical Labs
Sera Prognostics vs Aclarion
Over the past year SERA returned −45.9% and ACON returned −73.5%; their daily moves had a correlation of 0.09.
SERA −45.9% ACON −73.5%Growth of $1, one year, split-adjusted
| Metric | SERA | ACON |
|---|---|---|
| Price | $2.03 | $2.04 |
| Market cap | $80.1M | $5.9M |
| Today | −0.98% | +6.25% |
| 1 month | +1.0% | −14.3% |
| 6 months | +2.0% | −37.4% |
| Year to date | −31.2% | −55.7% |
| 1 year | −45.7% | −73.3% |
| Revenue growth (YoY) | +76.5% | +30.5% |
| Gross margin | −66.7% | 32.9% |
| Net margin | −30463.3% | −10899.5% |
| P/E (TTM) | — | — |
| Price / sales | 1,144.0× | 70.2× |
| Net cash | $46.4M | $16.3M |
| Dividend yield | — | — |
| Volatility (60d) | 34.0% | 67.7% |
| Short % of float | 0.7% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).